Santen RJ - Search Results

1

MICoA, a novel metastasis-associated protein 1 (MTA1) interacting protein coactivator, regulates estrogen receptor-alpha transactivation functions.

Mishra SK, Mazumdar A, Vadlamudi RK, Li F, Wang RA, Yu W, Jordan VC, Santen RJ, Kumar R. Mishra SK, et al. Among authors: santen rj. J Biol Chem. 2003 May 23;278(21):19209-19. doi: 10.1074/jbc.M301968200. Epub 2003 Mar 14. J Biol Chem. 2003. PMID: 12639951 Free article.

2

The role of Shc and insulin-like growth factor 1 receptor in mediating the translocation of estrogen receptor alpha to the plasma membrane.

Song RX, Barnes CJ, Zhang Z, Bao Y, Kumar R, Santen RJ. Song RX, et al. Among authors: santen rj. Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):2076-81. doi: 10.1073/pnas.0308334100. Epub 2004 Feb 5. Proc Natl Acad Sci U S A. 2004. PMID: 14764897 Free PMC article.

3

Adaptive hypersensitivity to estrogen: mechanism for sequential responses to hormonal therapy in breast cancer.

Santen RJ, Song RX, Zhang Z, Yue W, Kumar R. Santen RJ, et al. Clin Cancer Res. 2004 Jan 1;10(1 Pt 2):337S-45S. doi: 10.1158/1078-0432.ccr-031207. Clin Cancer Res. 2004. PMID: 14734489

4

The role of adapter protein Shc in estrogen non-genomic action.

Zhang Z, Kumar R, Santen RJ, Song RX. Zhang Z, et al. Among authors: santen rj. Steroids. 2004 Aug;69(8-9):523-9. doi: 10.1016/j.steroids.2004.05.012. Steroids. 2004. PMID: 15288764 Review.

5

Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells.

Jeng MH, Shupnik MA, Bender TP, Westin EH, Bandyopadhyay D, Kumar R, Masamura S, Santen RJ. Jeng MH, et al. Among authors: santen rj. Endocrinology. 1998 Oct;139(10):4164-74. doi: 10.1210/endo.139.10.6229. Endocrinology. 1998. PMID: 9751496

6

Linkage of rapid estrogen action to MAPK activation by ERalpha-Shc association and Shc pathway activation.

Song RX, McPherson RA, Adam L, Bao Y, Shupnik M, Kumar R, Santen RJ. Song RX, et al. Among authors: santen rj. Mol Endocrinol. 2002 Jan;16(1):116-27. doi: 10.1210/mend.16.1.0748. Mol Endocrinol. 2002. PMID: 11773443

7

Adaptive hypersensitivity to estrogen: mechanism for superiority of aromatase inhibitors over selective estrogen receptor modulators for breast cancer treatment and prevention.

Santen RJ, Song RX, Zhang Z, Kumar R, Jeng MH, Masamura S, Yue W, Berstein L. Santen RJ, et al. Endocr Relat Cancer. 2003 Jun;10(2):111-30. doi: 10.1677/erc.0.0100111. Endocr Relat Cancer. 2003. PMID: 12790774 Review.

8

The role of mitogen-activated protein (MAP) kinase in breast cancer.

Santen RJ, Song RX, McPherson R, Kumar R, Adam L, Jeng MH, Yue W. Santen RJ, et al. J Steroid Biochem Mol Biol. 2002 Feb;80(2):239-56. doi: 10.1016/s0960-0760(01)00189-3. J Steroid Biochem Mol Biol. 2002. PMID: 11897507 Review.

9

Adaptive mechanisms induced by long-term estrogen deprivation in breast cancer cells.

Song RX, Santen RJ, Kumar R, Adam L, Jeng MH, Masamura S, Yue W. Song RX, et al. Among authors: santen rj. Mol Cell Endocrinol. 2002 Jul 31;193(1-2):29-42. doi: 10.1016/s0303-7207(02)00093-x. Mol Cell Endocrinol. 2002. PMID: 12160999

10

Long-term estradiol deprivation in breast cancer cells up-regulates growth factor signaling and enhances estrogen sensitivity.

Santen RJ, Song RX, Zhang Z, Kumar R, Jeng MH, Masamura A, Lawrence J Jr, Berstein L, Yue W. Santen RJ, et al. Endocr Relat Cancer. 2005 Jul;12 Suppl 1:S61-73. doi: 10.1677/erc.1.01018. Endocr Relat Cancer. 2005. PMID: 16113100

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

371 results

Search Page

Filters